PubRank

Steven D Colan

Author PubWeight™ 321.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 56.72
2 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 41.47
3 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 26.95
4 Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 2007 6.22
5 Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol (1985) 2004 5.29
6 Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med 2014 5.11
7 Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006 4.51
8 Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010 3.96
9 Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr 2004 3.55
10 The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 2004 3.50
11 Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010 3.42
12 The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003 3.28
13 Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008 2.91
14 Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005 2.85
15 Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet 2013 2.82
16 Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 2007 2.76
17 Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004 2.68
18 Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation 2006 2.35
19 A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 2008 2.30
20 Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 2007 2.14
21 Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code. Cardiol Young 2008 2.10
22 A novel method of expressing left ventricular mass relative to body size in children. Circulation 2008 2.02
23 Sudden unexpected death after balloon valvuloplasty for congenital aortic stenosis. J Am Coll Cardiol 2010 2.02
24 Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004 1.89
25 Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging 2008 1.84
26 The nomenclature, definition and classification of cardiac structures in the setting of heterotaxy. Cardiol Young 2007 1.83
27 Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol 2010 1.83
28 Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet 2002 1.83
29 Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. J Pediatr 2002 1.80
30 Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 2002 1.78
31 Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006 1.75
32 Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J 2006 1.74
33 Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation 2013 1.67
34 Vascular health in Kawasaki disease. J Am Coll Cardiol 2013 1.67
35 Accuracy of echocardiography in low birth weight infants with congenital heart disease. Pediatrics 2005 1.65
36 Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006 1.61
37 Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006 1.59
38 Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 2004 1.52
39 Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol 2010 1.52
40 ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics 2005 1.46
41 Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study). Am J Cardiol 2009 1.45
42 Fontan physiology revisited. Anesth Analg 2015 1.43
43 Clinical utility of Doppler echocardiography in assessing aortic stenosis severity and predicting need for intervention in children. Pediatr Cardiol 2007 1.42
44 Wall stress misrepresents afterload in children and young adults with abnormal left ventricular geometry. J Appl Physiol (1985) 2002 1.38
45 Morphology of bicuspid aortic valve in children and adolescents. J Am Coll Cardiol 2004 1.35
46 The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 2010 1.34
47 Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr 2009 1.34
48 Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol 2004 1.32
49 Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol 2012 1.32
50 Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics 2007 1.31
51 The nomenclature, definition and classification of hypoplastic left heart syndrome. Cardiol Young 2006 1.31
52 Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. Am Heart J 2005 1.30
53 Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008 1.29
54 Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome. Am J Med Genet A 2011 1.24
55 Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 2010 1.22
56 Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 2005 1.21
57 Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol 2011 1.21
58 Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis. Circulation 2005 1.19
59 Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol 2013 1.17
60 Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol. J Clin Oncol 2002 1.16
61 Systolic and diastolic performance late after the Fontan procedure for a single ventricle and comparison of those undergoing operation at <12 months of age and at >12 months of age. Am J Cardiol 2002 1.16
62 Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study. JAMA Pediatr 2013 1.15
63 Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol 2009 1.11
64 Nomenclature and databases for the surgical treatment of congenital cardiac disease--an updated primer and an analysis of opportunities for improvement. Cardiol Young 2008 1.11
65 Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 2008 1.11
66 Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail 2010 1.10
67 Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol 2007 1.09
68 Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome. J Am Soc Echocardiogr 2013 1.09
69 Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 - Nomenclature of complications associated with interventional cardiology). Cardiol Young 2011 1.08
70 Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation 2011 1.06
71 Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis 2010 1.06
72 Update from the International Working Group for Mapping and Coding of Nomenclatures for Paediatric and Congenital Heart Disease. Cardiol Young 2004 1.06
73 Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 2011 1.05
74 Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation 2004 1.02
75 Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol 2012 1.02
76 Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy. Circ Cardiovasc Genet 2012 1.02
77 Factors associated with serum brain natriuretic peptide levels after the Fontan procedure. Congenit Heart Dis 2011 1.01
78 Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study. Am Heart J 2003 1.01
79 Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics 2006 1.01
80 Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional glenn anastomosis in infants with functional single ventricle: a prospective randomized trial. Circulation 2007 1.01
81 Improving outcomes in fetuses and neonates with congenital displacement (Ebstein's malformation) or dysplasia of the tricuspid valve. Am J Cardiol 2005 1.01
82 Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation 2013 1.00
83 Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol 2011 0.99
84 Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia. Cancer 2013 0.99
85 Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation 2009 0.99
86 Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation 2011 0.98
87 Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation 2012 0.97
88 Classification of the functionally univentricular heart: unity from mapped codes. Cardiol Young 2006 0.96
89 Noninvasive serial evaluation of myocardial mechanics in pressure overload hypertrophy of rabbit myocardium. Herz 2003 0.96
90 Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg 2010 0.96
91 Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res 2011 0.95
92 Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol 2004 0.95
93 Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J 2011 0.94
94 Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Pediatrics 2005 0.94
95 Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. Am Heart J 2012 0.93
96 The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1. AIDS 2012 0.92
97 Reproducibility of echocardiographic diagnosis of left ventricular noncompaction. J Am Soc Echocardiogr 2011 0.92
98 Prospective assessment after pediatric cardiac ablation: fate of intracardiac structure and function, as assessed by serial echocardiography. Am Heart J 2007 0.91
99 Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J 2010 0.91
100 Tissue velocity Doppler assessment of atrial and ventricular electromechanical coupling and atrioventricular time intervals in normal subjects. Am J Cardiol 2003 0.89
101 Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation 2012 0.88
102 Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr 2011 0.88
103 Left ventricular diastolic function in children and young adults with congenital aortic valve disease. Am J Cardiol 2012 0.88
104 Comparison of Fontan survivors with and without pacemakers: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Congenit Heart Dis 2012 0.88
105 Diastolic function in children with Kawasaki disease. Int J Cardiol 2009 0.88
106 Recombinant human growth hormone treatment for dilated cardiomyopathy in children. Pediatrics 2004 0.88
107 Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail 2009 0.88
108 Cardiac biomarkers in HIV-exposed uninfected children. AIDS 2013 0.88
109 Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med 2015 0.87
110 Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Pediatrics 2003 0.87
111 Adaptive mechanisms of left ventricular diastolic function to the physiologic load of pregnancy. Clin Cardiol 2002 0.87
112 Partial and transitional atrioventricular septal defect outcomes. Ann Thorac Surg 2010 0.86
113 A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children. Congenit Heart Dis 2011 0.86
114 Atrioventricular discordance with ventriculoarterial concordance: A remaining indication for the atrial switch operation. J Thorac Cardiovasc Surg 2004 0.86
115 Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Pediatrics 2012 0.86
116 Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers. AIDS 2015 0.86
117 Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging 2012 0.86
118 The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr Cardiol 2008 0.86
119 Limitations of expressing left ventricular mass relative to height and to body surface area in children. J Am Soc Echocardiogr 2012 0.86
120 Coronary artery dimensions in febrile children without Kawasaki disease. Circ Cardiovasc Imaging 2013 0.85
121 Bicuspid aortic valve and associated aortic dilation in the young. Heart 2012 0.85
122 Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: acute and intermediate effects on aortic valve function and left ventricular dimensions. J Thorac Cardiovasc Surg 2008 0.85
123 Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium. J Thorac Cardiovasc Surg 2009 0.85
124 Functional state following the Fontan procedure. Cardiol Young 2009 0.85
125 Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis. Circ Cardiovasc Interv 2012 0.85
126 Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 1 - Procedural nomenclature). Cardiol Young 2011 0.85
127 Non-geometric echocardiographic indices of ventricular function in patients with a Fontan circulation. J Am Soc Echocardiogr 2011 0.85
128 Echocardiographic predictors of left ventricular dysfunction after aortic valve surgery in children with chronic aortic regurgitation. Congenit Heart Dis 2012 0.84
129 Fetal diagnosis of interrupted aortic arch. Am J Cardiol 2010 0.84
130 Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohort. Congenit Heart Dis 2014 0.84
131 The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity. Leuk Lymphoma 2006 0.84
132 Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail 2013 0.84
133 Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant 2012 0.84
134 Familial restrictive cardiomyopathy with skeletal abnormalities. Am J Cardiol 2003 0.84
135 An echocardiographic model predicting severity of aortic regurgitation in congenital heart disease. Circ Cardiovasc Imaging 2010 0.83
136 Clinical outcomes and utility of cardiac catheterization prior to superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg 2003 0.83
137 The nomenclature, definition and classification of discordant atrioventricular connections. Cardiol Young 2006 0.83
138 Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virus. The Prospective P2C2 HIV Multicenter Study. Cardiovasc Pathol 2003 0.83
139 The why and how of Z scores. J Am Soc Echocardiogr 2013 0.82
140 Surgical interventions for atrioventricular septal defect subtypes: the pediatric heart network experience. Ann Thorac Surg 2011 0.82
141 Genetic variations in hypoxia response genes influence hypertrophic cardiomyopathy phenotype. Pediatr Res 2012 0.82
142 A shifting approach to management of the thoracic aorta in bicuspid aortic valve. J Thorac Cardiovasc Surg 2012 0.82
143 ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 2: pediatric training guidelines for noninvasive cardiac imaging endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography. J Am Coll Cardiol 2005 0.81
144 Technical performance scores in congenital cardiac operations: a quality assessment initiative. Ann Thorac Surg 2012 0.81
145 Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. Circ Cardiovasc Genet 2013 0.81
146 Report from the international society for nomenclature of paediatric and congenital heart disease: creation of a visual encyclopedia illustrating the terms and definitions of the international pediatric and congenital cardiac code. World J Pediatr Congenit Heart Surg 2010 0.81
147 Factors impacting echocardiographic imaging after the Fontan procedure: a report from the pediatric heart network fontan cross-sectional study. Echocardiography 2013 0.80
148 Heterogeneity of regional function and relation to ventricular morphology in patients with fontan circulation. Am J Cardiol 2013 0.80
149 Coronary artery dilation in sickle cell disease. J Pediatr 2011 0.79
150 Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study. Cardiovasc Toxicol 2004 0.79
151 Challenges in echocardiographic assessment of mitral regurgitation in children after repair of atrioventricular septal defect. Pediatr Cardiol 2011 0.79
152 Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs. Circulation 2005 0.79
153 Idiopathic and Primary Cardiomyopathies in Children. Prog Pediatr Cardiol 2008 0.79
154 The current status and future directions of efforts to create a global database for the outcomes of therapy for congenital heart disease. Cardiol Young 2005 0.79
155 Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circ Heart Fail 2012 0.79
156 Inadequate technical performance scores are associated with late mortality and late reintervention. Ann Thorac Surg 2013 0.79
157 Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery. Pediatr Crit Care Med 2016 0.78
158 ACCF/AHA/AAP recommendations for training in pediatric cardiology. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/AHA/AAP Writing Committee to Develop Training Recommendations for Pediatric Cardiology). Circulation 2005 0.78
159 Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant 2013 0.78
160 Echocardiographic predictors of mitral stenosis-related death or intervention in infants. Am Heart J 2008 0.78
161 Correlation of exercise response in repaired coarctation of the aorta to left ventricular mass and geometry. Am J Cardiol 2012 0.78
162 Factors associated with serum B-type natriuretic peptide in infants with single ventricles. Pediatr Cardiol 2014 0.78
163 Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection. Cardiol Young 2012 0.77
164 The relationship of patient medical and laboratory characteristics to changes in functional health status in children and adolescents after the Fontan procedure. Pediatr Cardiol 2013 0.77
165 Cardiac complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young 2008 0.76
166 Donald Charles Fyler: 1924–2011. Cardiol Young 2011 0.76
167 Midwall shortening after coarctation repair: the effect of through-plane motion on single-plane indices of left ventricular function. J Am Soc Echocardiogr 2005 0.75
168 Re: Reduction in levels of triidothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome. Cardiol Young 2002 0.75
169 Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J 2011 0.75
170 Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease. Clin Nephrol 2015 0.75
171 Left Ventricular Dysfunction Following Neonatal Pulmonary Valve Balloon Dilation for Pulmonary Atresia or Critical Pulmonary Stenosis. Pediatr Cardiol 2015 0.75
172 2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol 2017 0.75
173 Echocardiographic assessment of the right ventricular response to hypertension in neonates on the basis of average-shaped contraction models. J Am Soc Echocardiogr 2002 0.75
174 Mixed aortic valve disease in the young: initial observations. Pediatr Cardiol 2014 0.75
175 Aortic valve dysfunction and aortic dilation in adults with coarctation of the aorta. Congenit Heart Dis 2013 0.75
176 Changes in left atrioventricular valve geometry after surgical repair of complete atrioventricular canal. J Thorac Cardiovasc Surg 2011 0.75
177 Aortic translocation for the management of double-outlet right ventricle and pulmonary stenosis with dextrocardia: technique to avoid coronary insufficiency. Ann Thorac Surg 2010 0.75
178 Technical Performance Score Predicts Resource Utilization in Congenital Cardiac Procedures. J Am Coll Cardiol 2016 0.75